Advertisement
Singapore markets close in 6 hours 25 minutes
  • Straits Times Index

    3,323.36
    +9.22 (+0.28%)
     
  • Nikkei

    39,000.42
    +195.77 (+0.50%)
     
  • Hang Seng

    18,186.90
    +159.19 (+0.88%)
     
  • FTSE 100

    8,281.55
    +43.83 (+0.53%)
     
  • Bitcoin USD

    60,660.74
    -2,536.89 (-4.01%)
     
  • CMC Crypto 200

    1,255.50
    -54.22 (-4.14%)
     
  • S&P 500

    5,447.87
    -16.75 (-0.31%)
     
  • Dow

    39,411.21
    +260.88 (+0.67%)
     
  • Nasdaq

    17,496.82
    -192.54 (-1.09%)
     
  • Gold

    2,338.40
    -6.00 (-0.26%)
     
  • Crude Oil

    81.62
    -0.01 (-0.01%)
     
  • 10-Yr Bond

    4.2480
    -0.0090 (-0.21%)
     
  • FTSE Bursa Malaysia

    1,591.72
    +2.06 (+0.13%)
     
  • Jakarta Composite Index

    6,849.19
    -39.98 (-0.58%)
     
  • PSE Index

    6,294.16
    +21.70 (+0.35%)
     

Universal Health (UHS) Q1 Earnings Beat on Higher Admissions

Universal Health Services, Inc. UHS reported first-quarter 2023 adjusted earnings per share (EPS) of $2.34, which surpassed the Zacks Consensus Estimate by 8.8% and our estimate of $2.14. Additionally, the bottom line grew 8.8% year over year.

Net revenues of Universal Health advanced 5.3% year over year to $3,468 million in the quarter under review. The top line beat the consensus mark by 1.3% and our estimate of $3,415.5 million.

The strong quarterly results of UHS were supported by improved patient admissions at its acute care and behavioral healthcare facilities as well as rising patient days. However, the upside was partly offset by an elevated expense level.

Universal Health Services, Inc. Price, Consensus and EPS Surprise

 

Universal Health Services, Inc. Price, Consensus and EPS Surprise
Universal Health Services, Inc. Price, Consensus and EPS Surprise

Universal Health Services, Inc. price-consensus-eps-surprise-chart | Universal Health Services, Inc. Quote

 

Quarterly Operational Update

Adjusted earnings before interest, taxes, depreciation & amortization (EBITDA), net of net income attributable to noncontrolling interests (NCI), amounted to $421.1 million. The metric does not consider the impact of the provision for asset impairment and other (income) expenses, net. The figure improved 11% year over year and outpaced our estimate of $387.6 million.

ADVERTISEMENT

Total operating costs escalated 4.2% year over year to $3,188.8 million in the first quarter. This was mainly due to increased salaries, wages and benefits, other operating expenses, supplies, lease and rental expenses. The continued shortage of nurses and other medical personnel throughout the United States kept the company under pressure.

Segmental Update

Acute Care Hospital Services

Adjusted admissions (adjusted for outpatient activity) grew 10.5% year over year on a same-facility basis in the quarter under review, while adjusted patient days increased 3.7% year over year. Net revenues derived from Universal Health’s acute care services witnessed a 3.5% year-over-year uptick on a same-facility basis.

Behavioral Health Care Services

In the first quarter, adjusted admissions increased 7.5% year over year on a same-facility basis. Adjusted patient days advanced 4.7% year over year. Net revenues stemming from the behavioral healthcare services of UHS rose 9.7% year over year.

Financial Update (as of Mar 31, 2023)

Universal Health exited the first quarter with cash and cash equivalents of $110 million, which increased from $102.8 million at 2022-end.

As part of the $1.2-billion revolving credit facility of UHS, net of outstanding borrowings and letters of credit, there remains an aggregate available borrowing capacity of $875 million at the first-quarter end.

Total assets of $13,556 million increased from $13,494.2 million at 2022-end.

Long-term debt amounted to $4,707.3 million, down from $4,726.5 million at 2022-end. Short-term debt was at $96.2 million.

Total equity of $6,052.4 million rose 1.5% from the figure at 2022-end.

In the first quarter of 2023, net cash provided by operating activities declined 34.7% from the 2022-end level to $290.8 million. The plunge in this metric was caused by unfavorable other working capital accounts.

Share Repurchase Update

Universal Health bought back shares worth roughly $78.7 million in the first quarter. It had leftover funds of around $869 million under its repurchase authorization as of Mar 31, 2023.

2023 Guidance

Earlier management provided guidance for net revenues between $14,044 million and $14,314 million. This indicates an improvement of around 4.8%-6.8% from the 2022 figure of $13,399.4 million.

Adjusted EBITDA, net of NCI, was earlier anticipated in the band of $1,662-$1,753 million, the midpoint of which suggests 2.7% growth from the 2022 figure of $1,662 million.

UHS projected adjusted EPS in the range of $9.50-$10.50 for 2023, the midpoint of which implies 1.2% growth from the 2022 figure of $9.88.

Depreciation and amortization were estimated at $594.4 million. Interest expenses were projected at around $198 million. Capital expenditures were expected within $725 and $875 million.

Zacks Rank

Universal Health currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Recent Medical Sector Releases

Of the Medical sector players that have reported first-quarter results so far, the bottom lines of Elevance Health, Inc. ELV and UnitedHealth Group Incorporated UNH beat the Zacks Consensus Estimate, while the same for Centene Corporation CNC missed the Zacks Consensus Estimate.

Elevance Health reported first-quarter 2023 earnings of $9.46 per share, which beat the Zacks Consensus Estimate of $9.26 and our estimate of $9.22. Additionally, the bottom line advanced 15.5% year over year.

ELV’s operating revenues improved 10.6% year over year to $41,898 million in the quarter under review. The top line beat the consensus mark by 2.5% and came higher than our estimate of $40,766.5 million.

UnitedHealth Group reported first-quarter 2023 adjusted earnings of $6.26 per share, which beat the Zacks Consensus Estimate of $6.24 and our estimate of $6.17. The bottom line improved from the $5.49 per share reported a year ago.

The company’s quarterly performance was driven by sustained membership growth in its UnitedHealthcare business. Strong expansion in value-based arrangements in the Optum Health segment also contributed to the upside, partly offset by elevated operating costs.

Centene Corporation reported first-quarter 2023 adjusted EPS of $2.11, which lagged the Zacks Consensus Estimate by 5.4%. However, the bottom line advanced 15.3% year over year.

Revenues of CNC amounted to $38,889 million, which improved 4.6% year over year. The top line outpaced the consensus mark by 7.1%.

The quarterly results took a hit from escalating medical costs. Nevertheless, the downside was partly offset by a growing premium base stemming from solid membership growth within most of its business lines and numerous contract wins.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report

Universal Health Services, Inc. (UHS) : Free Stock Analysis Report

Centene Corporation (CNC) : Free Stock Analysis Report

Elevance Health, Inc. (ELV) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research